SINGAPORE attracted some S$13.5 billion in fixed asset investment (FAI) commitments in 2024, over half of which were in ...

Leveragen has announced a strategic partnership with Moonlight Bio, targeting the development of T-cell therapies for ...

Scientists have pioneered a groundbreaking method to combat snake venom using newly designed proteins, offering hope for more ...

ImmunoPrecise Antibodies Ltd. (“IPA” or the “Company”) (NASDAQ: IPA), a leader in AI-driven antibody discovery and development, today announced the successful completion of its previously disclosed ...

Each year, over two million people fall victim to snakebites, resulting in more than 100,000 fatalities and 300,000 severe disabilities, according to the World Health Organization. These alarming ...

"This is probably the coolest experimental result I've had in my career so far," said biochemist Susana Vázquez Torres.

Scientists have discovered a new type of anti-malarial antibody that doesn't interfere with current vaccines, at least in mouse models. Could they help eliminate malaria in the future? https://p ...

AUSTIN, Texas--(BUSINESS WIRE)--ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ: IPA) has developed a new class of GLP-1 therapies entirely through artificial intelligence, designed to enhance ...

Experts said a certain type of bispecific antibody seems to have hit upon a crucial combination of two cancer targets: the proteins VEGF and either PD-1 or PD-L1. “It’s exactly that,” said ...

JAKARTA, Jan 22 (Reuters) - Indonesia's President Prabowo Subianto is considering pardons for prisoners linked to armed organisations in the restive easternmost province of Papua, including ...

About ImmunoPrecise Antibodies Ltd. ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and ...

(“Innate” or the “Company”) will host an event for institutional investors and analysts dedicated to its Antibody-Drug Conjugate (ADC) strategy, and particularly Nectin-4, the target of ...